This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William F. G. Tucker, MB, MRCP; Ronald E. Church, MD, FRCP
Rupert Hallam Department of Dermatology Royal Hallamshire Hospital Glossop Road Sheffield, England S10 2JF

Arch Dermatol. 1984;120(9):1140.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

We were interested to read the April ARCHIVES case report by James and Odom¹ describing transverse white lines in the fingernails following chemotherapy and the subsequent short report in the July ARCHIVES by Wantzin and Thomsen² of pigmented nail bands, nail shedding, and acute paronychia following high-dose methotrexate therapy. Both sets of authors attributed the nail changes to an alteration of nail growth, and Wantzin and Thomsen postulated that this was the consequence of a direct cytotoxic action on the nail matrix and paronychium.

We have long been surprised that Beau's lines and striate leukonychia, which probably both represent disturbances in nail growth of varying severity, are so seldom seen in patients undergoing systemic chemotherapy with methotrexate for psoriasis. A course of regular chemotherapy with razoxane (ICRF 159) ( ± )1,2-bis (3,5-dioxopiperazin-1-yl) propane was recently started for a 70-year-old man with severe psoriasis. This is a . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter     What's this?